Le Lézard
Classified in: Business, Covid-19 virus
Subjects: EARNINGS, Conference Call, Webcast

Tennant Company Reports Record 2023 Fourth-Quarter and Full-Year Results


Tennant Company ("Tennant" or the "Company") (NYSE: TNC) today reported its fourth-quarter and full-year financial results for 2023.

(In millions, except per share data)

Three Months Ended
December 31,

 

Twelve Months Ended
December 31,

 

2023

 

2022

 

% Change

 

2023

 

2022

 

% Change

Net sales

$

311.4

 

 

$

291.0

 

 

7.0

%

 

$

1,243.6

 

 

$

1,092.2

 

 

13.9

%

Net income

$

31.0

 

 

$

23.8

 

 

30.3

%

 

$

109.5

 

 

$

66.3

 

 

65.2

%

Diluted EPS

$

1.64

 

 

$

1.27

 

 

29.1

%

 

$

5.83

 

 

$

3.55

 

 

64.2

%

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted diluted EPS

$

1.92

 

 

$

1.46

 

 

31.5

%

 

$

6.57

 

 

$

4.10

 

 

60.2

%

Adjusted EBITDA

$

41.5

 

 

$

41.7

 

 

(0.5

)%

 

$

192.9

 

 

$

133.7

 

 

44.3

%

Adjusted EBITDA margin %

 

13.3

%

 

 

14.3

%

 

(100 bps)

 

 

15.5

%

 

 

12.2

%

 

330 bps

Highlights

"We are pleased to report Tennant's strong fourth-quarter results, continuing the trend of positive results over the past six quarters," said Dave Huml, Tennant president and chief executive officer. "Our full-year results represent record achievements for the company in terms of net sales, adjusted EBITDA and EBITDA margin. We saw full-year organic growth across all geographies and product categories as our price realization effectively offset inflationary pressures. The exceptional teamwork and dedication displayed across the company, particularly in efforts to meaningfully reduce backlog, have been pivotal to our success this year."

"As we enter 2024, our strategic focus centers on our new enterprise strategy," continued Huml. "We are targeting to deliver long-term revenue growth, expand margins, and continue to generate strong cash flow. We have already begun to activate specific growth initiatives in the areas of new product innovation, expanded go-to-market strategies and disciplined pricing. We are excited about our position and have confidence in our ability to drive sustained long-term growth."

Net Sales Results

Consolidated net sales for the fourth quarter 2023 totaled $311.4 million, a 7.0% increase compared to $291.0 million in the fourth quarter of 2022. Consolidated net sales for the full year 2023 totaled $1,243.6 million, a 13.9% increase compared to $1,092.2 million in 2022. The components of the consolidated net sales change were as follows:

 

 

Three Months Ended
December 31,

 

Twelve Months Ended
December 31,

 

 

2023 vs. 2022

 

2023 vs. 2022

Price

 

5.9%

 

8.7%

Volume

 

(0.5)%

 

4.9%

Organic growth

 

5.4%

 

13.6%

Foreign currency

 

1.6%

 

0.3%

Total growth

 

7.0%

 

13.9%

Organic Sales

Organic sales, which excludes the effects of foreign currency, grew in both the fourth quarter and full year 2023 compared to 2022. This growth was driven by price realization across all regions and by volume growth in equipment sales, particularly in the Americas. At December 31, 2023, the Company's backlog was approximately $186 million, a reduction of $28 million in the fourth quarter and $140 million for the full year.

 

Three Months Ended December 31, 2023

 

Twelve Months Ended December 31, 2023

 

Americas

 

EMEA

 

APAC

 

Total

 

Americas

 

EMEA

 

APAC

 

Total

Organic net sales growth

7.3

%

 

(0.6

)%

 

9.6

%

 

5.4

%

 

18.9

%

 

2.6

%

 

8.6

%

 

13.6

%

Americas: The 7.3% growth in the Americas during the fourth quarter resulted from price realization in North America partially offset by volume declines. The 18.9% growth during the full year was driven equally by price realization and increased volume across all geographies.

EMEA: The 0.6% decline in EMEA during the fourth quarter was driven by volume declines in equipment sales partially offset by growth in parts and consumables and service. The 2.6% increase during the full year was propelled by price realization in all product categories, though EMEA volumes were impacted by weaker-than-expected market conditions.

APAC: The 9.6% increase in APAC during the fourth quarter and 8.6% increase during the full year were driven by price realization in Australia and volume increases in Australia and China.

Operating Results

Gross profit margin increased to 42.0% in the fourth quarter, a 240-basis-point improvement from 2022. Adjusted gross profit margin increased to 42.2% in the fourth quarter of 2023, a 250-basis-point improvement from 2022. For the full year 2023, gross profit margin increased to 42.4% compared to 38.5% in 2022. Adjusted gross profit margin increased to 42.5% for the full year 2023, a 390-basis-point improvement compared to 2022. The increase in both periods was driven primarily by price realization, but also cost-out activities and plant productivity, which offset inflation in the year.

In the fourth quarter of 2023, selling and administrative ("S&A") expense as a percentage of sales increased to 30.7%, up from 27.2% in 2022. Adjusted S&A expense as a percentage of sales for the fourth quarter 2023 increased to 29.9%, up from 27.0% in 2022. Full-year S&A expense as a percentage of sales increased to 28.4% in 2023, compared to 28.0% in 2022. Adjusted S&A expense as a percentage of sales increased to 28.0% in 2023, compared to 27.9% in 2022. Rate increases in both periods were primarily attributed to higher variable costs linked to improved operating performance as well as strategic investments to deliver future growth.

Adjusted EBITDA was $41.5 million in the fourth quarter of 2023, down slightly compared to $41.7 million in 2022. Adjusted EBITDA margin for the fourth quarter 2023 was 13.3%, a 100-basis-point decline from 2022. The decline was primarily driven by higher variable costs linked to improved operating performance, strategic growth investments within S&A, and elevated research and development (R&D) expense due to timing of project spend.

Adjusted EBITDA was $192.9 million for the full year 2023, compared to $133.7 million in the prior-year period. The improvement in adjusted EBITDA was primarily due to strong sales growth, driven by both volume and price, and gross margin expansion. Adjusted EBITDA margin was 15.5% in 2023, a 330-basis-point increase over the prior-year period benefiting from operating leverage created by sales growth.

Net income was $31.0 million in the fourth quarter of 2023, a $7.2 million increase compared to the fourth quarter of 2022. The increase was primarily driven by a lower effective tax rate due to a discrete nonrecurring and noncash item. Net income for the full year 2023 was $109.5 million, an increase of $43.2 million compared to 2022. The increase was primarily driven by favorable operating results and a lower tax rate discussed above partly offset by higher interest expense.

Cash Flow, Capital Allocation and Liquidity

Cash generated from operations for the full year 2023 totaled $188.4 million, a $213.5 million increase compared to 2022. The increase was driven by strong operating performance and moderating investments in working capital. The Company converted 150% of net income to free cash flow in 2023.

Liquidity remained strong with a balance of $117.1 million in cash and cash equivalents as of the end of 2023 and $336.8 million of unused borrowing capacity on the Company's revolving credit facility.

The Company continues to allocate capital with a disciplined approach and consistent priorities, which include making strategic investments in our business to drive long-term profitable growth, returning cash to shareholders through dividends and share repurchases, and managing within our debt leverage goals. The Company invested $22.8 million in capital expenditures and reduced outstanding debt by $100.0 million in 2023. The Company returned $41.8 million to shareholders through a combination of $20.1 million in dividends and repurchasing 290,920 shares for $21.7 million.

Guidance

The Company is introducing full-year 2024 guidance.

"Building on the momentum of a record 2023, our focus in 2024 is on rigorous execution in the first year of our new enterprise growth strategy, continuing to meaningfully reduce backlog, allocating capital in line with our stated capital priorities, and actively pursuing accretive acquisitions aligned to our M&A strategy," said Huml.

For the full year 2024, the Company is targeting organic net sales growth between 2% and 4% split equally between price and volume growth. The year-over-year growth reflects an expected reduction in backlog between $80 and $100 million for the full year 2024 compared to $140 million in 2023. The Company expects continued strong price realization and cost-out activities to favorably impact gross margins and will remain disciplined in spending, focusing on areas that position it for growth and enhanced operating efficiencies.

(In millions except per share data)

2024
Guidance Range

Net sales

$1,270 - $1,295

Organic net sales growth

2.0 % - 4.0 %

Adjusted diluted net income per share*

$6.05 - $6.65

Adjusted EBITDA*

$198 - $213

Adjusted EBITDA margin*

15.6 % - 16.4 %

Capital expenditures*

$20 - $25

Adjusted effective tax rate*

22 % - 27 %

*Excludes ERP modernization costs, other certain nonoperational items and amortization expense.

Conference Call

Tennant will host a conference call to discuss its 2023 fourth-quarter and full-year results today, February 22, 2024, at 10 a.m. Central Time (11 a.m. Eastern Time). The conference call and accompanying slides will be available via webcast on Tennant's investor website. To listen to the call live and view the slide presentation, go to investors.tennantco.com and click on the link at the bottom of the home page. A replay of the conference call, with slides, will be available at investors.tennantco.com.

About Tennant Company

Founded in 1870, Tennant Company (NYSE: TNC), headquartered in Eden Prairie, Minnesota, is a world leader in the design, manufacture and marketing of solutions that help create a cleaner, safer and healthier world. Its innovative products include equipment for maintaining surfaces in industrial, commercial and outdoor environments; detergent-free and other sustainable cleaning technologies; and cleaning tools and supplies. Tennant's global field service network is the most extensive in the industry. Tennant Company had sales of $1.24 billion in 2023 and has approximately 4,457 employees. Tennant has manufacturing operations throughout the world and sells products directly in 15 countries and through distributors in more than 100 countries. For more information, visit www.tennantco.com and www.ipcworldwide.com.

Forward-Looking Statements

Certain statements contained in this document are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements do not relate to strictly historical or current facts and provide current expectations or forecasts of future events. Any such expectations or forecasts of future events are subject to a variety of factors. These include factors that affect all businesses operating in a global market as well as matters specific to us and the markets the Company serves. Particular risks and uncertainties presently facing it include: geopolitical and economic uncertainty throughout the world; uncertainty surrounding the impacts and duration of the COVID-19 pandemic; the Company's ability to comply with global laws and regulations; the Company's ability to adapt to customer pricing sensitivities; the competition in the Company's business; fluctuations in the cost, quality or availability of raw materials and purchased components; the Company's ability to adjust pricing to respond to cost pressures; unforeseen product liability claims or product quality issues; the Company's ability to attract, retain and develop key personnel and create effective succession planning strategies; the Company's ability to effectively develop and manage strategic planning and growth processes and the related operational plans; the Company's ability to successfully upgrade and evolve its information technology systems; the Company's ability to successfully protect our information technology systems from cybersecurity risks; the occurrence of a significant business interruption; the Company's ability to maintain the health and safety of its workers; the Company's ability to integrate acquisitions; and the Company's ability to develop and commercialize new innovative products and services.

The Company cautions that forward-looking statements must be considered carefully and that actual results may differ in material ways due to risks and uncertainties both known and unknown. Information about factors that could materially affect the Company's results can be found in our 2023 Form 10-K, when filed. Shareholders, potential investors and other readers are urged to consider these factors in evaluating forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.

The Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Investors are advised to consult any further disclosures by the Company in its filings with the Securities and Exchange Commission and in other written statements on related subjects. It is not possible to anticipate or foresee all risk factors, and investors should not consider any list of such factors to be an exhaustive or complete list of all risks or uncertainties.

Non-GAAP Financial Measures

This news release and the related conference call include presentation of Non-GAAP measures that include or exclude special items of a nonrecurring and/or nonoperational nature (hereinafter referred to as "special items"). Management believes that the Non-GAAP measures provide useful information to investors regarding the Company's results of operations and financial condition because they permit a more meaningful comparison and understanding of Tennant Company's operating performance for the current, past or future periods. Management uses these Non-GAAP measures to monitor and evaluate ongoing operating results and trends and to gain an understanding of the comparative operating performance of the Company.

The Company believes that disclosing gross profit ? as adjusted, gross margin ? as adjusted, selling and administrative ("S&A") expense ? as adjusted, S&A expense as a percent of net sales ? as adjusted, operating income ? as adjusted, operating margin ? as adjusted, income before income taxes ? as adjusted, income tax expense ? as adjusted, net income ? as adjusted, net income per diluted share ? as adjusted, EBITDA ? as adjusted, and EBITDA margin ? as adjusted (collectively, the "Non-GAAP measures"), excluding the impacts from special items, is useful to investors as a measure of operating performance. The Company use these measures to monitor and evaluate operating performance. The Non-GAAP measures are financial measures that do not reflect United States Generally Accepted Accounting Principles (GAAP). The Company calculates the Non-GAAP measures by adjusting for gain on sale of assets, restructuring-related charges, acquisition-contingent consideration, loss on extinguishment of debt, and amortization expense. The Company calculates

income tax expense ? as adjusted by adjusting for the tax effect of these Non-GAAP measures. The Company calculates net income per diluted share ? as adjusted by adjusting for the after-tax effect of these Non-GAAP measures and dividing the result by the diluted weighted average shares outstanding. The Company calculates EBITDA margin ? as adjusted by dividing EBITDA ? as adjusted by net sales.

FINANCIAL TABLES FOLLOW

TENNANT COMPANY

CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

 

(In millions, except shares and per share data)

Three Months Ended
December 31,

 

Twelve Months Ended
December 31,

 

2023

 

2022

 

2023

 

2022

Net sales

$

311.4

 

 

$

291.0

 

 

$

1,243.6

 

 

$

1,092.2

 

Cost of sales

 

180.6

 

 

 

175.8

 

 

 

715.8

 

 

 

671.3

 

Gross profit

 

130.8

 

 

 

115.2

 

 

 

527.8

 

 

 

420.9

 

Selling and administrative expense

 

95.7

 

 

 

79.2

 

 

 

352.6

 

 

 

306.3

 

Research and development expense

 

10.6

 

 

 

7.6

 

 

 

36.6

 

 

 

31.1

 

Gain on sale of assets

 

?

 

 

 

?

 

 

 

?

 

 

 

(3.7

)

Operating income

 

24.5

 

 

 

28.4

 

 

 

138.6

 

 

 

87.2

 

Interest expense, net

 

(2.5

)

 

 

(3.4

)

 

 

(13.5

)

 

 

(7.1

)

Net foreign currency transaction (loss) gain

 

(0.2

)

 

 

(0.8

)

 

 

0.3

 

 

 

(1.2

)

Other income (expense), net

 

0.2

 

 

 

0.5

 

 

 

(1.6

)

 

 

0.6

 

Income before income taxes

 

22.0

 

 

 

24.7

 

 

 

123.8

 

 

 

79.5

 

Income tax (benefit) expense

 

(9.0

)

 

 

0.9

 

 

 

14.3

 

 

 

13.2

 

Net income

$

31.0

 

 

$

23.8

 

 

$

109.5

 

 

$

66.3

 

 

 

 

 

 

 

 

 

Net income per share

 

 

 

 

 

 

 

Basic

$

1.67

 

 

$

1.29

 

 

$

5.92

 

 

$

3.58

 

Diluted

$

1.64

 

 

$

1.27

 

 

$

5.83

 

 

$

3.55

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

 

 

 

 

 

Basic

 

18,579,763

 

 

 

18,490,547

 

 

 

18,509,523

 

 

 

18,494,356

 

Diluted

 

18,906,887

 

 

 

18,685,605

 

 

 

18,783,633

 

 

 

18,697,255

 

GEOGRAPHICAL NET SALES(1) (Unaudited)

   

 

Three Months Ended
December 31,

 

Twelve Months Ended
December 31,

 

2023

 

2022

 

% Change

 

2023

 

2022

 

% Change

Americas

$

208.1

 

$

193.2

 

7.7

%

 

$

840.3

 

$

705.9

 

19.0

%

Europe, Middle East and Africa

 

80.3

 

 

76.6

 

4.8

%

 

 

314.4

 

 

301.6

 

4.2

%

Asia Pacific

 

23.0

 

 

21.2

 

8.5

%

 

 

88.9

 

 

84.7

 

5.0

%

Total

$

311.4

 

$

291.0

 

7.0

%

 

$

1,243.6

 

$

1,092.2

 

13.9

%

(1) Net of intercompany sales.

TENNANT COMPANY

CONSOLIDATED BALANCE SHEETS (Unaudited)

 

(In millions)

 

 

 

December 31

2023

 

2022

ASSETS

 

 

 

Cash, cash equivalents, and restricted cash

$

117.1

 

 

$

77.4

 

Receivables, less allowances of $7.2 and $6.1, respectively

 

247.6

 

 

 

251.5

 

Inventories

 

175.9

 

 

 

206.6

 

Prepaid and other current assets

 

28.5

 

 

 

39.8

 

Total current assets

 

569.1

 

 

 

575.3

 

Property, plant and equipment, less accumulated depreciation of $304.0 and $279.3, respectively

 

187.7

 

 

 

179.9

 

Operating lease assets

 

41.7

 

 

 

31.8

 

Goodwill

 

187.4

 

 

 

182.0

 

Intangible assets, net

 

63.1

 

 

 

76.4

 

Other assets

 

64.4

 

 

 

39.7

 

Total assets

$

1,113.4

 

 

$

1,085.1

 

LIABILITIES AND TOTAL EQUITY

 

 

 

Current portion of long-term debt

$

6.4

 

 

$

5.2

 

Accounts payable

 

111.4

 

 

 

126.1

 

Employee compensation and benefits

 

67.3

 

 

 

44.0

 

Other current liabilities

 

88.6

 

 

 

86.3

 

Total current liabilities

 

273.7

 

 

 

261.6

 

Long-term debt

 

194.2

 

 

 

295.1

 

Long-term operating lease liabilities

 

27.4

 

 

 

17.1

 

Employee-related benefits

 

13.3

 

 

 

13.2

 

Deferred income taxes

 

5.0

 

 

 

11.5

 

Other liabilities

 

21.5

 

 

 

14.5

 

Total long-term liabilities

 

261.4

 

 

 

351.4

 

Total liabilities

 

535.1

 

 

 

613.0

 

Common stock, $0.375 par value per share, 60,000,000 shares authorized; 18,631,384 and 18,521,485 issued and outstanding, respectively

 

7.0

 

 

 

7.0

 

Additional paid-in capital

 

64.9

 

 

 

56.0

 

Retained earnings

 

547.4

 

 

 

458.0

 

Accumulated other comprehensive loss

 

(42.3

)

 

 

(50.2

)

Total Tennant Company shareholders' equity

 

577.0

 

 

 

470.8

 

Noncontrolling interest

 

1.3

 

 

 

1.3

 

Total equity

 

578.3

 

 

 

472.1

 

Total liabilities and total equity

$

1,113.4

 

 

$

1,085.1

 

 

 

 

 

TENNANT COMPANY

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

 

(In millions)

 

Years ended December 31

2023

 

2022

OPERATING ACTIVITIES

 

 

 

Net income

$

109.5

 

 

$

66.3

 

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

 

 

 

Depreciation expense

 

36.4

 

 

 

32.8

 

Amortization expense

 

14.7

 

 

 

15.9

 

Deferred income tax benefit

 

(26.9

)

 

 

(15.6

)

Share-based compensation expense

 

11.6

 

 

 

7.8

 

Bad debt and returns expense

 

3.4

 

 

 

2.3

 

Gain on sale of assets

 

?

 

 

 

(3.7

)

Other, net

 

1.3

 

 

 

1.0

 

Changes in operating assets and liabilities:

 

 

 

Receivables

 

4.1

 

 

 

(46.3

)

Inventories

 

14.3

 

 

 

(68.3

)

Accounts payable

 

(15.3

)

 

 

7.7

 

Employee compensation and benefits

 

22.3

 

 

 

(14.8

)

Other assets and liabilities

 

13.0

 

 

 

(10.2

)

Net cash provided by (used in) operating activities

 

188.4

 

 

 

(25.1

)

INVESTING ACTIVITIES

 

 

 

Purchases of property, plant and equipment

 

(22.8

)

 

 

(25.0

)

Other, net

 

?

 

 

 

0.1

 

Proceeds from sale of assets, net of cash divested

 

?

 

 

 

4.1

 

Investment in leased assets

 

(1.2

)

 

 

(4.3

)

Cash received from leased assets

 

0.8

 

 

 

0.6

 

Net cash used in investing activities

 

(23.2

)

 

 

(24.5

)

FINANCING ACTIVITIES

 

 

 

Proceeds from borrowings

 

20.0

 

 

 

52.0

 

Repayments of borrowings

 

(120.0

)

 

 

(19.1

)

Change in finance lease obligations

 

0.2

 

 

 

?

 

Proceeds (repurchases) from exercise of stock options, net of employee tax withholdings obligations

 

19.0

 

 

 

(0.9

)

Dividends paid

 

(20.1

)

 

 

(18.9

)

Repurchases of common stock

 

(21.7

)

 

 

(5.0

)

Net cash (used in) provided by financing activities

 

(122.6

)

 

 

8.1

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

(2.9

)

 

 

(4.7

)

Net increase (decrease) in cash, cash equivalents and restricted cash

 

39.7

 

 

 

(46.2

)

Cash, cash equivalents and restricted cash at beginning of year

 

77.4

 

 

 

123.6

 

Cash, cash equivalents and restricted cash at end of year

$

117.1

 

 

$

77.4

 

TENNANT COMPANY

SUPPLEMENTAL NON-GAAP FINANCIAL TABLES

Reported to Adjusted Net Income and Net Income Per Share

 

(In millions, except per share data)

Three Months Ended
December 31,

 

Twelve Months Ended
December 31,

 

2023

 

2022

 

2023

 

2022

Net income - as reported

$

31.0

 

$

23.8

 

$

109.5

 

$

66.3

 

Adjustments:

 

 

 

 

 

 

 

Gain on sale of assets

 

?

 

 

?

 

 

?

 

 

(2.8

)

Amortization expense

 

2.7

 

 

2.7

 

 

10.6

 

 

11.5

 

Restructuring-related charge (Cost of sales)

 

0.5

 

 

0.2

 

 

0.5

 

 

0.2

 

Restructuring-related charge (S&A expense)

 

0.8

 

 

0.5

 

 

1.6

 

 

1.3

 

ERP modernization (S&A expense)

 

1.2

 

 

?

 

 

1.2

 

 

?

 

Net income - as adjusted

$

36.2

 

$

27.2

 

$

123.4

 

$

76.5

 

 

 

 

 

 

 

 

 

Net income per share - as reported:

 

 

 

 

 

 

 

Diluted

$

1.64

 

$

1.27

 

$

5.83

 

$

3.55

 

Adjustments:

 

 

 

 

 

 

 

Gain on sale of assets

 

?

 

 

?

 

 

?

 

 

(0.15

)

Amortization expense

 

0.14

 

 

0.15

 

 

0.56

 

 

0.62

 

Restructuring-related charge (Cost of sales)

 

0.03

 

 

0.01

 

 

0.03

 

 

0.01

 

Restructuring-related charge (S&A expense)

 

0.05

 

 

0.03

 

 

0.09

 

 

0.07

 

ERP modernization (S&A expense)

 

0.06

 

 

?

 

 

0.06

 

 

?

 

Net income per diluted share - as adjusted

$

1.92

 

$

1.46

 

$

6.57

 

$

4.10

 

TENNANT COMPANY

SUPPLEMENTAL NON-GAAP FINANCIAL TABLES

Reported Net Income to Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA)

 

(In millions)

Three Months Ended
December 31,

 

Twelve Months Ended
December 31,

 

2023

 

2022

 

2023

 

2022

Net income - as reported

$

31.0

 

 

$

23.8

 

 

$

109.5

 

 

$

66.3

 

Less:

 

 

 

 

 

 

 

Interest expense, net

 

2.5

 

 

 

3.4

 

 

 

13.5

 

 

 

7.1

 

Income tax expense

 

(9.0

)

 

 

0.9

 

 

 

14.3

 

 

 

13.2

 

Depreciation expense

 

10.0

 

 

 

8.8

 

 

 

36.4

 

 

 

32.8

 

Amortization expense

 

3.7

 

 

 

3.8

 

 

 

14.7

 

 

 

15.9

 

EBITDA

$

38.2

 

 

$

40.7

 

 

$

188.4

 

 

$

135.3

 

Adjustments:

 

 

 

 

 

 

 

Gain on sale of assets

 

?

 

 

 

?

 

 

 

?

 

 

 

(3.7

)

Restructuring-related charge (Cost of sales)

 

0.7

 

 

 

0.3

 

 

 

0.7

 

 

 

0.3

 

Restructuring-related charge (S&A expense)

 

1.0

 

 

 

0.7

 

 

 

2.2

 

 

 

1.8

 

ERP modernization (S&A expense)

 

1.6

 

 

 

?

 

 

 

1.6

 

 

 

?

 

EBITDA - as adjusted

$

41.5

 

 

$

41.7

 

 

$

192.9

 

 

$

133.7

 

EBITDA margin - as adjusted

 

13.3

%

 

 

14.3

%

 

 

15.5

%

 

 

12.2

%

TENNANT COMPANY

SUPPLEMENTAL NON-GAAP FINANCIAL TABLES

Reported to Adjusted Gross Profit, Selling and Administrative Expense (S&A expense) and Operating Income

 

(In millions)

Three Months Ended
December 31,

 

Twelve Months Ended
December 31,

 

2023

 

2022

 

2023

 

2022

Gross profit - as reported

$

130.8

 

 

$

115.2

 

 

$

527.8

 

 

$

420.9

 

Gross margin - as reported

 

42.0

%

 

 

39.6

%

 

 

42.4

%

 

 

38.5

%

Adjustments:

 

 

 

 

 

 

 

Restructuring-related charge (Cost of sales)

 

0.7

 

 

 

0.3

 

 

 

0.7

 

 

 

0.3

 

Gross profit - as adjusted

$

131.5

 

 

$

115.5

 

 

$

528.5

 

 

$

421.2

 

Gross margin - as adjusted

 

42.2

%

 

 

39.7

%

 

 

42.5

%

 

 

38.6

%

 

 

 

 

 

 

 

 

S&A expense - as reported

$

95.7

 

 

$

79.2

 

 

$

352.6

 

 

$

306.3

 

S&A expense as a percent of net sales - as reported

 

30.7

%

 

 

27.2

%

 

 

28.4

%

 

 

28.0

%

Adjustments:

 

 

 

 

 

 

 

Restructuring-related charge (S&A expense)

 

(1.0

)

 

 

(0.7

)

 

 

(2.2

)

 

 

(1.8

)

ERP modernization (S&A expense)

 

(1.6

)

 

 

?

 

 

 

(1.6

)

 

 

?

 

S&A expense - as adjusted

$

93.1

 

 

$

78.5

 

 

$

348.8

 

 

$

304.5

 

S&A expense as a percent of net sales - as adjusted

 

29.9

%

 

 

27.0

%

 

 

28.0

%

 

 

27.9

%

 

 

 

 

 

 

 

 

Operating income - as reported

$

24.5

 

 

$

28.4

 

 

$

138.6

 

 

$

87.2

 

Operating margin - as reported

 

7.9

%

 

 

9.8

%

 

 

11.1

%

 

 

8.0

%

Adjustments:

 

 

 

 

 

 

 

Restructuring-related charge (Cost of sales)

 

0.7

 

 

 

0.3

 

 

 

0.7

 

 

 

0.3

 

Gain on sale of assets

 

?

 

 

 

?

 

 

 

?

 

 

 

(3.7

)

Restructuring-related charge (S&A expense)

 

1.0

 

 

 

0.7

 

 

 

2.2

 

 

 

1.8

 

ERP modernization (S&A expense)

 

1.6

 

 

 

?

 

 

 

1.6

 

 

 

?

 

Operating income - as adjusted

$

27.8

 

 

$

29.4

 

 

$

143.1

 

 

$

85.6

 

Operating margin - as adjusted

 

8.9

%

 

 

10.1

%

 

 

11.5

%

 

 

7.8

%

TENNANT COMPANY

SUPPLEMENTAL NON-GAAP FINANCIAL TABLES

Reported to Adjusted Income Before Income Taxes and Income Tax Expense

 

(In millions)

Three Months Ended
December 31,

 

Twelve Months Ended
December 31,

 

2023

 

2022

 

2023

 

2022

Income before income taxes - as reported

$

22.0

 

 

$

24.7

 

 

$

123.8

 

 

$

79.5

 

Adjustments:

 

 

 

 

 

 

 

Gain on sale of assets

 

?

 

 

 

?

 

 

 

?

 

 

 

(3.7

)

Amortization expense

 

3.7

 

 

 

3.8

 

 

 

14.7

 

 

 

15.9

 

Restructuring-related charge (Cost of sales)

 

0.7

 

 

 

0.3

 

 

 

0.7

 

 

 

0.3

 

Restructuring-related charge (S&A expense)

 

1.0

 

 

 

0.7

 

 

 

2.2

 

 

 

1.8

 

ERP modernization (S&A expense)

 

1.6

 

 

 

?

 

 

 

1.6

 

 

 

?

 

Income before income taxes - as adjusted

$

29.0

 

 

$

29.5

 

 

$

143.0

 

 

$

93.8

 

 

 

 

 

 

 

 

 

Income tax expense - as reported

$

(9.0

)

 

$

0.9

 

 

$

14.3

 

 

$

13.2

 

Effective tax rate - as reported

 

(40.9

)%

 

 

3.6

%

 

 

11.6

%

 

 

16.6

%

Adjustments(1):

 

 

 

 

 

 

 

Gain on sale of assets

 

?

 

 

 

?

 

 

 

 

 

(0.9

)

Amortization expense

 

1.0

 

 

 

1.1

 

 

 

4.1

 

 

 

4.4

 

Restructuring-related charge (Cost of sales)

 

0.2

 

 

 

0.1

 

 

 

0.2

 

 

 

0.1

 

Restructuring-related charge (S&A expense)

 

0.2

 

 

 

0.2

 

 

 

0.6

 

 

 

0.5

 

ERP modernization (S&A expense)

 

0.4

 

 

 

?

 

 

 

0.4

 

 

 

?

 

Income tax expense - as adjusted

$

(7.2

)

 

$

2.3

 

 

$

19.6

 

 

$

17.3

 

Effective tax rate - as adjusted

 

(24.8

)%

 

 

7.8

%

 

 

13.7

%

 

 

18.4

%

(1) In determining the tax impact, we applied the statutory rate in effect for each jurisdiction where income or expenses were generated.

 


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: